Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 700

recruiting
3 968
countries
28
conditions
2 103

10 282 trials match your criteria

Influenza

Not recruiting

Study of intravenous zanamivir safety and effectiveness in infants under 6 months of age with complicated influenza infection

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Zanamivir

Multiple sclerosis

Not recruiting

Study on the Effects of SAR443820 and Gadobutrol in Patients with Multiple Sclerosis

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Gadobutrol

Study on the Long-Term Safety and Effectiveness of Losmapimod for Patients with Facioscapulohumeral Muscular Dystrophy (FSHD)

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Losmapimod

Psoriasis

Not recruiting

Study on the Safety, Effectiveness, and Blood Movement of Bimekizumab in Adolescents with Moderate to Severe Plaque Psoriasis

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Bimekizumab

Study on Tranexamic Acid to Reduce Bleeding and Transfusion Needs in Patients Undergoing Major Abdominal Surgery

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride

Study on AVP-786 for Treating Agitation in Alzheimer's Dementia Patients

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Quinidine Sulfate

Diabetic nephropathy+2

Not recruiting

Remote Study on Empagliflozin and Finerenone for Reducing Kidney Issues in Type 2 Diabetes Patients

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Empagliflozin

Partial seizures

Not recruiting

Study on the Safety and Effectiveness of Cenobamate for Children with Focal Seizures

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Cenobamate

Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab

Neoplasm malignant

Not recruiting

Study of BT5528 alone and with nivolumab in patients with advanced solid tumors that have EphA2 protein expression

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab

Study on the Effectiveness of Platelet-Rich Plasma and Hyaluronic Acid vs. Estriol for Women with Menopausal Genitourinary Syndrome

Registered drugNo placebo
Countries:SpainSpain
  • Participants:65+ years
  • Substances:Estriol

Study of Mavacamten for Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Investigational
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Mavacamten
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.